Completed PHASE2 INTERVENTIONAL 2-arm NCT06592547

Intravenous Metoprolol in Septic Shock

EFFECT of INTRAVENOUS METOPROLOL TARTRATE on MORTALITY in PATIENTS with SEPTIC SHOCK DUE to VENTILATOR-ASSOCIATED PNEUMONIA Thesis

Sponsor: Alexandria University

Conditions Septic Shock Ventilator Acquired Pneumonia

Interventions Intravenous metoprolol tartrate Standard Care (in control arm)

Updated 2 times since 2024 Last updated: Jan 28, 2025 Started: Apr 1, 2022 Primary completion: Dec 1, 2023 Completion: Nov 10, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06592547, this PHASE2 trial focuses on Septic Shock and Ventilator Acquired Pneumonia and remains completed. Sponsored by Alexandria University, it has been updated 2 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

2 versions recorded

Feb 2025 — Present [monthly]

Completed PHASE2

Status: Active Not Recruiting → Completed
Oct 2024 — Feb 2025 [monthly]

Active Not Recruiting PHASE2

First recorded

Apr 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alexandria University

Data source: Alexandria University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Alexandria, Egypt